Data gathered: April 15
AI Stock Analysis - Caribou Biosciences (CRBU)
Analysis generated December 9, 2024. Powered by Chat GPT.
Caribou Biosciences is a biotechnology firm specializing in genome editing technology. Leveraging CRISPR technology, the company aims to develop transformative therapeutic solutions. Caribou focuses on cutting-edge science to create treatments for serious diseases, which places it in a high-risk, high-reward bracket of the biotech industry.
Stock Alerts - Caribou Biosciences (CRBU)
 |
Caribou Biosciences | April 14 Price is down by -7.5% in the last 24h. |
|
Caribou Biosciences | April 11 Price is up by 7.7% in the last 24h. |
|
Caribou Biosciences | April 10 Price is down by -6.2% in the last 24h. |
|
Caribou Biosciences | April 9 Price is up by 6.3% in the last 24h. |
Alternative Data for Caribou Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 6 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| Patents | 45 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 14 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,380 | Sign up | Sign up | Sign up |
| Twitter Followers | 6,513 | Sign up | Sign up | Sign up |
| Twitter Mentions | 31 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 48 | Sign up | Sign up | Sign up |
| Linkedin Employees | 173 | Sign up | Sign up | Sign up |
About Caribou Biosciences
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally.
| Price | $0.80 |
| Target Price | Sign up |
| Volume | 955,270 |
| Market Cap | $81M |
| Year Range | $0.76 - $2.79 |
| Dividend Yield | 0% |
| Analyst Rating | 86% buy |
| Industry | Medical Devices |
In the news
 |
Intech Investment Management LLC Increases Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)March 29 - ETF Daily News |
|
Analysts Set Caribou Biosciences, Inc. (NASDAQ:CRBU) PT at $10.33March 28 - ETF Daily News |
|
Q1 Earnings Estimate for CRBU Issued By HC WainwrightMarch 22 - ETF Daily News |
|
HC Wainwright Reiterates “Buy” Rating for Caribou Biosciences (NASDAQ:CRBU)March 21 - ETF Daily News |
|
Equities Analysts Issue Forecasts for CRBU FY2029 EarningsMarch 13 - ETF Daily News |
|
Brookline Capital Management Predicts CRBU Q1 EarningsMarch 13 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 2.1M | 0 | 2.1M | -35M | -38M | -0.387 |
| Q3 '24 | 2M | 0 | 2M | -35M | -38M | -0.382 |
| Q2 '24 | 3.5M | 860,000 | 2.6M | -38M | -43M | -0.436 |
| Q1 '24 | 2.4M | 710,000 | 1.7M | -41M | -45M | -0.460 |
| Q4 '23 | 3.6M | 2M | 1.6M | -35M | -37M | -0.390 |
Insider Transactions View All
| Haurwitz Rachel E. filed to buy 3,369,395 shares at $1. March 17 '25 |
| MCCLUNG BARBARA G filed to sell 443,502 shares at $1.4. February 21 '25 |
| Kanner Steven filed to sell 431,556 shares at $1.4. February 21 '25 |
| Khan Ruhi Ahmad filed to sell 66,936 shares at $1.4. February 21 '25 |
| Ryali Sriram filed to buy 17,360 shares at $1.4. January 30 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$94.27 0% | 72 |
 |
Edwards LifesciencesEW |
$69.87 0% | 32 |
 |
Intuitive SurgicalISRG |
$490.13 0% | 66 |
 |
MedtronicMDT |
$84.22 0% | 47 |
 |
StrykerSYK |
$353.42 0% | 48 |
Read more about Caribou Biosciences (CRBU) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Caribou Biosciences?
The Market Cap of Caribou Biosciences is $81M.
What is the current stock price of Caribou Biosciences?
Currently, the price of one share of Caribou Biosciences stock is $0.80.
How can I analyze the CRBU stock price chart for investment decisions?
The CRBU stock price chart above provides a comprehensive visual representation of Caribou Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Caribou Biosciences shares. Our platform offers an up-to-date CRBU stock price chart, along with technical data analysis and alternative data insights.
Does CRBU offer dividends to its shareholders?
As of our latest update, Caribou Biosciences (CRBU) does not offer dividends to its shareholders. Investors interested in Caribou Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Caribou Biosciences?
Some of the similar stocks of Caribou Biosciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.